Inactive Instrument
Synergy Pharmaceuticals Inc Stock Nasdaq
Stocks
US8716393082
Biotechnology & Medical Research
| 1 day | -52.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Leslie M. Magnus
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2015 |
Stephen Comiskey
PRN | Corporate Officer/Principal | - | 15/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -52.00% | -62.59% | - | - | 0 | |
| -3.25% | +13.72% | +52.49% | +88.86% | 64.9B | |
| +0.69% | +0.96% | +29.39% | +68.41% | 54.05B | |
| -1.07% | -1.79% | -18.07% | -14.36% | 23.16B | |
| +33.86% | +30.60% | +19.14% | +502.77% | 21.46B | |
| +1.87% | +9.47% | +30.87% | -7.94% | 21.25B | |
| -0.79% | +1.79% | +36.31% | -25.84% | 17.94B | |
| -3.37% | +25.85% | +213.21% | +369.13% | 17.03B | |
| +3.29% | +5.61% | +21.01% | +586.49% | 14.99B | |
| -7.94% | -6.74% | +38.42% | +157.52% | 14.25B | |
| Average | -2.87% | +6.57% | +46.97% | +191.67% | 27.67B | |
| Weighted average by Cap. | +1.74% | +6.97% | +43.32% | +147.01% |
Employees
-
